ruthenium has been researched along with naphthalimides in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bright, SA; Elmes, RB; Erby, M; Gunnlaugsson, T; Williams, DC | 1 |
| Elmes, RB; Erby, M; Gunnlaugsson, T; Poynton, FE; Quinn, SJ; Ryan, GJ; Williams, DC | 1 |
| Li, J; Sun, Y; Tan, L; Zhao, H | 1 |
| Frias, C; Jones, PG; Keppler, BK; Misgeld, R; Ott, I; Prokop, A; Streciwilk, W; Terenzi, A | 1 |
| Bandow, JE; Cheng, X; Dabiri, Y; Hager, L; Keppler, BK; Ott, I; Prochnow, P; Streciwilk, W; Terenzi, A; Wölfl, S | 1 |
| Blagojevic, B; Cheng, X; Dabiri, Y; Ott, I; Schmid, A; Streciwilk, W; Theobald, J; Wölfl, S | 1 |
| Chen, X; Liu, Z; Ma, W; Tian, Z; Xia, X; Xu, Z; Zhang, S; Zhang, Y | 1 |
| Elmes, RBP; Erby, ML; Frimannsson, DO; Gunnlaugsson, T; Kitchen, JA; Lawler, M; Quinn, SJ; Ryan, GJ; Williams, DC | 1 |
| Kumar, A; Mishra, R; Patra, AK; Sivakumar, S; Srivastava, P; Verma, M | 1 |
| Blasco, S; Estalayo-Adrián, S; Gunnlaugsson, T; la Cour Poulsen, B; McManus, GJ; Mohan, B; Shanmugaraju, S; Umadevi, D | 1 |
| Gunnlaugsson, T; Quinn, SJ; Ryan, GJ | 1 |
| Bisceglie, F; Carcelli, M; Orsoni, N; Pelagatti, P; Pelosi, G; Pinelli, S; Pioli, M; Sadler, PJ | 1 |
12 other study(ies) available for ruthenium and naphthalimides
| Article | Year |
|---|---|
Photophysical and biological investigation of novel luminescent Ru(II)-polypyridyl-1,8-naphthalimide Tröger's bases as cellular imaging agents.
Topics: Cell Survival; Contrast Media; HeLa Cells; Humans; Luminescent Agents; Molecular Structure; Naphthalimides; Pyridines; Ruthenium | 2012 |
Unexpected DNA binding properties with correlated downstream biological applications in mono vs. bis-1,8-naphthalimide Ru(II)-polypyridyl conjugates.
Topics: Cell Survival; Circular Dichroism; Coordination Complexes; DNA; HeLa Cells; Humans; Microscopy, Confocal; Naphthalimides; Nucleic Acid Denaturation; Photolysis; Ruthenium; Spectrophotometry, Ultraviolet; Transition Temperature; Ultraviolet Rays | 2015 |
Ruthenium(II) polypyridyl complexes with 1,8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα.
Topics: Antigens, Neoplasm; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Naphthalimides; Ruthenium; Topoisomerase Inhibitors | 2016 |
Metal NHC Complexes with Naphthalimide Ligands as DNA-Interacting Antiproliferative Agents.
Topics: Apoptosis; Cell Proliferation; Circular Dichroism; Coordination Complexes; Crystallography, X-Ray; Cymenes; DNA; Drug Stability; HT29 Cells; Humans; Intercalating Agents; Ligands; MCF-7 Cells; Methane; Molecular Conformation; Monoterpenes; Naphthalimides; Rhodium; Ruthenium; Spectrophotometry, Ultraviolet | 2017 |
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorescent Dyes; G-Quadruplexes; Humans; Intercalating Agents; Ligands; Naphthalimides; Neoplasms; Organometallic Compounds; Rhodium; Ruthenium | 2018 |
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway.
Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Heterocyclic Compounds; Humans; Ligands; Membrane Potential, Mitochondrial; Methane; Mitochondria; Naphthalimides; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Ruthenium; Signal Transduction | 2018 |
Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Iridium; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Naphthalimides; Neoplasms; Ruthenium | 2019 |
Synthesis, Characterization, and Biological Profiling of Ruthenium(II)-Based 4-Nitro- and 4-Amino-1,8-naphthalimide Conjugates.
Topics: 1-Naphthylamine; Cell Proliferation; Coordination Complexes; DNA; HeLa Cells; Humans; K562 Cells; Molecular Structure; Naphthalimides; Nitro Compounds; Optical Imaging; Quinolones; Ruthenium | 2020 |
Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; DNA; DNA Damage; Drug Screening Assays, Antitumor; Humans; Luminescence; Microscopy, Fluorescence; Models, Molecular; Molecular Structure; Naphthalimides; Optical Imaging; Photosensitizing Agents; Ruthenium; Transferrin | 2021 |
Design, Synthesis, and Anticancer Studies of a
Topics: 1-Naphthylamine; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Curcumin; Cymenes; Humans; Naphthalimides; Quinolones; Ruthenium; Spectroscopy, Fourier Transform Infrared | 2022 |
Hook, Line, and Sinker! Spectroscopic Studies of Bi-Modular Mono- and Bis-1,8-naphthalimide-Ru(bpy)
Topics: Coordination Complexes; DNA; Naphthalimides; Ruthenium; Spectrum Analysis | 2022 |
Light Triggers the Antiproliferative Activity of Naphthalimide-Conjugated (η
Topics: A549 Cells; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Molecular Structure; Naphthalimides; Ruthenium | 2022 |